Jonathan Levy
Impact in
Papers in
- Oncology 5
- Colorectal Cancer Treatments and Studies 3
- Cancer Immunotherapy and Biomarkers 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Christopher J. Sweeney (5 shared papers)Funda Meric‐Bernstam (5 shared papers)Howard A. Burris (5 shared papers)John D. Hainsworth (5 shared papers)Charles Swanton (5 shared papers)Katja Schulze (5 shared papers)Razelle Kurzrock (5 shared papers)Claire F. Friedman (5 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)The Lancet Oncology (1 paper)Biometrics (1 paper)Cancer Research (1 paper)Epidemiology (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Jonathan Levy
9 papers receiving 416 citations
Jonathan Levy's Hit Papers
Peers
Comparison fields: 5 of 38
- Oncology 243
- Surgery 239
- Cancer Research 66
- Pathology and Forensic Medicine 63
- Pulmonary and Respiratory Medicine 111
Countries citing papers authored by Jonathan Levy
This map shows the geographic impact of Jonathan Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Levy more than expected).
Fields of papers citing papers by Jonathan Levy
This network shows the impact of papers produced by Jonathan Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Levy. The network helps show where Jonathan Levy may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study Hit paper breakdown → | 2021 | 263 |
| 2 | 2021 | 63 | |
| 3 | 2023 | 39 | |
| 4 | 2021 | 32 | |
| 5 | 2020 | 8 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 7 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 1 |
About Jonathan Levy
Jonathan Levy is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Statistics and Probability, Cancer Research and Surgery, having authored 9 papers that have together received 422 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Genomics and Diagnostics (2 papers), Advanced Causal Inference Techniques (2 papers), HER2/EGFR in Cancer Research (2 papers), Urban, Neighborhood, and Segregation Studies (1 paper), Health disparities and outcomes (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Oncology (243 citations), Surgery (239 citations), Cancer Research (66 citations), Pathology and Forensic Medicine (63 citations) and Pulmonary and Respiratory Medicine (111 citations). Jonathan Levy has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Christopher J. Sweeney, Funda Meric‐Bernstam, Howard A. Burris, John D. Hainsworth, Charles Swanton, Katja Schulze, Razelle Kurzrock, Claire F. Friedman, Arisha Patel and David R. Spigel. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, Biometrics, Cancer Research and Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.